9th July 2021
Synthomer plc
Appointment of Non-Executive Director
Synthomer plc ('Synthomer' or 'the Company') today announces that it has appointed Roberto Gualdoni as a Non-Executive Director. He will join the Board with immediate effect and become a member of the Audit, Remuneration and Nomination Committees. Roberto replaces Just Jansz, who will be stepping down from the Board at the end of August 2021 following nine years' service.
Roberto has considerable chemicals sector experience following more than 25 years at BASF. During that time, he held senior operational roles covering international sales, marketing, procurement and M&A and served on a number of joint venture Boards. His final role at BASF was as President of its Styrenics business, which was carved out as part of a joint venture as Styrolution, and which Roberto led as Chief Executive for three years until 2014.
Roberto is currently Chair of CABB Group, a private speciality chemicals manufacturer, and a member of the Board of Directors of Aerogel Corporation, a private bio-pharma cold-chain services provider. Previously, he has served on the Boards of SABIC, Outokumpu Oyj and Carmeuse.
Caroline Johnstone, Chair of Synthomer, said:
"I am delighted to welcome Roberto to Synthomer's Board. His extensive knowledge of the international chemicals industry, and wealth of Board-level experience, will be enormously valuable as we continue to execute our strategy and invest in future growth. On behalf of the Board, I would also like to thank Just for his considerable contribution to Synthomer over the last nine years."
There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.
-ENDS-
Enquiries:
Tim Hughes - President, Corporate Development | Tel +44 1279 436211 |
Charles Armitstead/ Matt Denham - Teneo | Tel +44 7703 330 269/ +44 7825 735 596 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.